Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Codexis Inc

CDXS
Current price
3.05 USD -0.04 USD (-1.29%)
Last closed 3.14 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 234 251 232 USD
Yield for 12 month +5.90 %
1Y
3Y
5Y
10Y
15Y
CDXS
21.11.2021 - 28.11.2021

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.13 USD

P/E ratio

Dividend Yield

Current Year

+70 143 000 USD

Last Year

+138 590 000 USD

Current Quarter

+17 073 000 USD

Last Quarter

+26 561 000 USD

Current Year

+51 816 000 USD

Last Year

+100 557 000 USD

Current Quarter

+10 966 000 USD

Last Quarter

+22 483 000 USD

Key Figures CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -37 792 000 USD
Operating Margin TTM -69.63 %
PE Ratio
Return On Assets TTM -14.65 %
PEG Ratio -1.16
Return On Equity TTM -63.45 %
Wall Street Target Price 7.13 USD
Revenue TTM 74 234 000 USD
Book Value 1.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 31.5 %
Dividend Yield
Gross Profit TTM 20 458 000 USD
Earnings per share -0.94 USD
Diluted Eps TTM -0.94 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -87.73 %

Dividend Analytics CDXS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CDXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 138.8889
Enterprise Value Revenue 2.1867
Price Sales TTM 2.8766
Enterprise Value EBITDA -3.4178
Price Book MRQ 2.3376

Financials CDXS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CDXS

For 52 weeks

1.45 USD 4.91 USD
50 Day MA 3.26 USD
Shares Short Prior Month 2 297 114
200 Day MA 2.68 USD
Short Ratio 4.51
Shares Short 2 027 334
Short Percent 3.71 %

Dynamics of changes in the value of assets

Stocks


AAPL

AAPL

212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds


S

SX7EEX

13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics